http://rdcu.be/GxI4
phase 3 clinical trial on a new injectable medication for BPH. the medication had a reduced need for BPH intervention and acute urinary retention.
Sounds exciting!
Will have to review this paper further to look at improvement in symptom scores, which appear modest at first glance, as well as quantitative measures of improvement like flow rate.